Open original FDA record ↗Recall record
- FDA identifier
- Z-0639-2010
- Company in FDA record
- Exelint International Co.
- FDA classification date
- Jan 22, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Coring of port's septum, which may lead to: Decreased effectiveness of port, infection, necrosis, swelling, and embolization, which may result in Pulmonary Embolism, Limb ischemia, stroke, local extravasation of medication such as chemotherapy or other caustic material, may lead to local tissue necrosis, granulomas, failure to deliver therapy, need for additional surgery to replace implanted port
Source facts
- Action
- Distributors have been advised to cease distribution of any recalled needles and infusion sets; to quarantine any remaining; to document amount on Customer Response Form; to return form to Exel (firm); to arrange for return of product to Exel for credit. Distributors also are advised to share recall notice with all affected customers. Contact phone: 727-827-1922x0 (M-F 9a-5p EST). Contact email: info@exelint.com
- Initiated
- 2009-12-23
- Root cause
- Device Design
- Terminated
- 2011-06-06
- Distribution
- US (VA TX NV KY OH NH MS NY OH NM DE WA AZ IL PA OR CO FL GA LA UT MI WI NV CA NJ MO IA) and Canada.
- Recall number
- Z-0639-2010
- Recall status
- Terminated
- CDRH record ID
- 87821
- FDA classified
- 2010-01-22
- Recall event number
- 54203